Daniel Paul Regan, Chief Commercial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1 shares at $250.00 ($250) on 2014-07-03, disclosed to the SEC on 2014-07-08.
Scheduled sale ($250) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2014-08-15 | $2.6M | — | Filing → |
| ICPT | SELL | 2014-03-07 | $8.7M | — | Filing → |